Research Deep Dive

Financing Healthcare’s Next Deal Cycle

How private credit, leverage, valuation discipline and operating pressure are reshaping investment across the healthcare economy

The Compounding Crisis: How Demographic Aging Is Redrawing the Healthcare Economy

Revenue Cycle Management: Healthcare’s Next Margin Defense

Revenue cycle management was once treated as a back-office function: submit the claim, chase the denial and collect the payment.

The GLP-1 Revolution: Reshaping Healthcare's Value Chain

GLP-1 therapies are evolving beyond obesity treatment into a platform capable of transforming chronic disease management, healthcare spending, and investment across the healthcare ecosystem.

Artificial Intelligence Is Becoming Healthcare's Next Infrastructure Layer

Healthcare has reached an AI inflection point. After three years dominated by experimentation, the industry is shifting from exploring what Generative AI can do to determining where it can deliver measurable economic value.

Healthcare M&A 2026: The Return of Strategic Capital

Healthcare M&A is entering a new chapter. After several years marked by rising interest rates, valuation resets, and regulatory uncertainty, the market is beginning to recover, but not in the way many expected.

Robotics in Healthcare: From Assistive Tools to Core Infrastructure

Market Overview: Robotics Moves Into the Healthcare Mainstream

Healthcare M&A Sentiment: Optimism Returns, but Discipline Defines the Next Cycle

Healthcare M&A sentiment is improving as the industry moves toward 2026, supported by stabilizing financing markets, renewed strategic interest, and growing confidence that the post-2021 slowdown has largely bottomed out.

Precision Medicine 2030: The Convergence of Genomics, AI, and Personalized Care

Precision medicine is rapidly transforming from a niche clinical concept into one of the defining trends shaping the future of healthcare and life sciences.

The Margin Playbook in an Era of Structural Cost Pressure

The healthcare industry has entered a new economic regime.

From Breakout Growth to Capital Discipline: Why Biopharma Returns Are Losing Momentum

The biotechnology sector has long occupied a unique position within global capital markets.

Home Healthcare

How Aging Demographics, AI, and Decentralized Care Are Transforming the Future of Global Healthcare